Director Shareholding

GlaxoSmithKline PLC 5 January 2001 Directors' Interests in GlaxoSmithKline plc Ordinary Shares I give below details of the directors' interests in the Ordinary Shares ('Shares') and American Depositary Shares (which represent two Shares) ('ADSs') of GlaxoSmithKline plc ('the Company') as of the commencement of trading of the Company : Name of director Number of Total holdings as a % of share Notes Shares class Sir Richard Sykes 538,665 0.00866 a Sir Roger Hurn 10,539 0.00017 Sir Peter Walters 31,398 0.00050 Dr Jean-Pierre 105,694 0.00170 b Garnier John Coombe 164,203 0.00264 c Paul Allaire 12,830 0.00021 b Michele Barzach 812 0.00001 Derek Bonham 8,445 0.00014 Sir Christopher Hogg 5,121 0.00008 Peter Job 2,003 0.00003 John McArthur 7,116 0.00011 b Donald McHenry 12,080 0.00019 b Sir Ian Prosser 2,315 0.00004 Dr Ronaldo Schmitz 7,504 0.00012 b Dr Lucy Shapiro 3,697 0.00006 d John Young 19,650 0.00032 d Notes: a. Includes a non-beneficial interest in a trust which holds 36,612 Shares. b. Shares held as ADSs. c. Includes a non-beneficial interest in a trust which holds 20,397 Shares. d. Includes Shares and ADSs. The following directors have interests in Shares arising from the grant of options under Glaxo Wellcome plc share option plans: Name of Number of Shares Exercise Earliest date Expiry director over which options price from which options date are held £ are exercisable Sir 92,236 16.10 27/12/2000 03/02/2003 Richard Sykes 542,465 14.60 27/12/2000 24/08/2003 248 (SAYE) 13.27 27/12/2000 30/06/2001 John 41,739 16.10 27/12/2000 03/08/2009 Coombe 245,479 14.60 25/02/2003 24/02/2010 730 (SAYE) 13.27 1/12/2002 31/05/2003 The following director has an interest in ADSs arising from the grant of options under SmithKline Beecham plc share option plans: Name of Number of ADSs Exercise Earliest date Expiry director over which options price from which options date are held $ are exercisable Dr 77,370 12.892091 24/11/1996 23/11/2003 Jean-Pierre Garnier 28,582 12.870518 31/05/1997 30/05/2004 163,161 16.087083 20/07/1997 19/07/2004 231,052 14.530536 22/11/1997 21/11/2004 79,054 22.067443 15/11/1998 14/11/2005 68,411 28.159051 21/11/1999 20/11/2006 68,411 32.086995 24/03/2000 23/03/2007 225,324 40.536028 23/05/2000 12/11/2007 225,324 54.481547 23/05/2000 22/11/2008 341,400 61.353251 23/05/2000 14/03/2009 566,724 60.307557 23/05/2000 23/11/2009 The following directors have an interest in the Company's Shares arising from Awards made under the Glaxo Wellcome Long Term Incentive Plan: Name of director Number of Shares Award date Release date Sir Richard Sykes 56,519 12/03/1998 31/12/2000 39,969 24/03/1999 31/12/2000 50,856 25/02/2000 31/12/2000 John Coombe 25,120 12/03/1998 12/03/2001 18,087 24/03/1999 24/03/2002 23,013 25/02/2000 25/02/2003 The following director has an interest in the Company's ADSs arising from Awards made under the SmithKline Beecham Mid-Term Incentive Plan: Name of Number of Grant Award Deferred until director ADSs over date date (a) which interest is held Dr Jean-Pierre 18,891 07/06/1996 15/03/1999 Deferred until Garnier 15/03/2002 18,891 21/11/1996 09/03/2000 Deferred until 09/03/2003 18,891 24/03/1997 09/03/2000 Deferred until 09/03/2003 18,891 13/11/1997 31/12/2000 - 36,985 23/11/1998 31/12/2001 - 36,985 24/11/1999 31/12/2002 - Note: (a) After the grant has vested on the award date, the director may elect to defer receipt of the award for a three year period or until retirement. S M Bicknell Company Secretary 5th January 2001

Companies

GSK (GSK)
UK 100

Latest directors dealings